Clinical Trial Update: Safety and Early Signs of Efficacy of IL12-L19L19. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and early signs of efficacy of IL12-L19L19 in patients with advanced or metastatic solid tumors; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• IL12-L19L19 (IL-12-L19L19 fusion protein)

Snippet

Sponsor: Philogen S.p.A. | Conditions: Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Status: RECRUITING